HomeDRMA • NASDAQ
Dermata Therapeutics Inc
add
$3.42
0.29%
After Hours:(0.58%)-0.020
$3.40
Closed: Oct 31, 7:50:41 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.77M | -38.53% |
Net income | -1.70M | 39.87% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.48M | 31.00% |
Total assets | 6.64M | 26.81% |
Total liabilities | 1.03M | -46.50% |
Total equity | 5.61M | — |
Shares outstanding | 681.56K | — |
Price to book | 0.39 | — |
Return on assets | -53.25% | — |
Return on capital | -68.63% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.70M | 39.87% |
Cash from operations | -2.69M | -26.55% |
Cash from investing | — | — |
Cash from financing | -547.86K | -123.42% |
Net change in cash | -3.24M | -1,617.36% |
Free cash flow | -2.62M | -142.72% |
Previous close
$3.43
Day range
$3.40 - $3.50
Year range
$3.40 - $23.70
Market cap
2.33M USD
Avg Volume
249.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
8
